Risk of development of medication overuse headache with nonsteroidal anti-inflammatory drug therapy for migraine: A critically appraised topic

Amaal J. Starling, Charlene Hoffman-Snyder, Rashmi B. Halker, Kay E. Wellik, Bert B. Vargas, David W. Dodick, Bart M. Demaerschalk, Dean M. Wingerchuk

Research output: Contribution to journalArticle

17 Scopus citations

Abstract

Background: The development of medication overuse headache (MOH) is associated with frequent use of analgesics, especially opiates, for treatment of primary headache disorders, particularly migraine. Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to treat migraine. Objective: To critically evaluate evidence estimating the risk of MOH associated with NSAID therapy in patients with migraine. Methods: The objective was addressed through the development of a structured, critically appraised topic. This included a clinical scenario, structured question, literature search strategy, critical appraisal, results, evidence summary, commentary, and bottom line conclusions. Participants included consultant and resident neurologists, a medical librarian, clinical epidemiologists, and headache neurology content experts. Results: The 1-year incidence of MOH was 2.5%. In patients with low (0 to 4 d monthly) to moderate (5 to 9 d monthly) baseline headache frequency, NSAIDs were not associated with progression to MOH and may be protective (odds ratio=0.31; 95% confidence interval, 0.27-0.34). However, in patients with a high baseline headache frequency (10 to 14 d monthly), NSAIDs are associated with progression to MOH (odds ratio=1.93; 95% confidence interval, 1.82-2.06). Conclusions:: Acute NSAID therapy is associated with progression to MOH in migraineurs with a high baseline migraine frequency but may be protective in patients with low baseline headache frequency. However, a causal role for NSAIDs in progression from episodic to chronic headache has not been established.

Original languageEnglish (US)
Pages (from-to)297-299
Number of pages3
JournalNeurologist
Volume17
Issue number5
DOIs
StatePublished - Sep 1 2011

    Fingerprint

Keywords

  • critically appraised topic
  • evidence-based medicine
  • medication overuse headache
  • migraine disorders
  • nonsteroidal anti-inflammatory drugs

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Starling, A. J., Hoffman-Snyder, C., Halker, R. B., Wellik, K. E., Vargas, B. B., Dodick, D. W., Demaerschalk, B. M., & Wingerchuk, D. M. (2011). Risk of development of medication overuse headache with nonsteroidal anti-inflammatory drug therapy for migraine: A critically appraised topic. Neurologist, 17(5), 297-299. https://doi.org/10.1097/NRL.0b013e31822d109c